Genetic determinants of 5-lipoxygenase transcription

被引:18
作者
Drazen, JM
Silverman, ES
机构
[1] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
关键词
leukotrienes; asthma; Egr-1; Sp-1; gene transcription;
D O I
10.1159/000024098
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: 5 Lipoxygenase (5-LO) is a critical enzyme in the production of the leukotrienes, We have identified a series of mutations in the 5-LO gene that modify gene transcription. These mutations consist of addition of an Sp-l binding motif (-GGGCGG-) or deletion of one or two Sp-l binding motifs in the 5-LO core promoter. Methods: Mutant forms of the 5-LO core promoter were placed in a chloramphenicol acetyl transferase (CAT) reporter construct using either HeLa or SL-2 cells. Results: In HeLa cells all of the mutant forms are less effective in driving CAT reporter activity than the wild-type promoter. In SL-2 cells the construct containing the addition mutation was more effective in driving CAT reporter activity, while the constructs containing the deletion mutations were less effective. Conclusions: These data indicate that naturally occurring mutations in the 5-LO core promoter modify gene transcription in vitro.
引用
收藏
页码:275 / 278
页数:4
相关论文
共 15 条
[1]   The role of leukotrienes in asthma and allergic rhinitis [J].
Busse, WW .
CLINICAL AND EXPERIMENTAL ALLERGY, 1996, 26 (08) :868-879
[2]   ROLE OF PHOSPHOLIPASES IN GENERATING LIPID 2ND MESSENGERS IN SIGNAL TRANSDUCTION [J].
DENNIS, EA ;
RHEE, SG ;
BILLAH, MM ;
HANNUN, YA .
FASEB JOURNAL, 1991, 5 (07) :2068-2077
[3]   CHARACTERIZATION OF THE HUMAN 5-LIPOXYGENASE GENE PROMOTER [J].
HOSHIKO, S ;
RADMARK, O ;
SAMUELSSON, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (23) :9073-9077
[4]   Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription [J].
In, KH ;
Asano, K ;
Beier, D ;
Grobholz, J ;
Finn, PW ;
Silverman, EK ;
Silverman, ES ;
Collins, T ;
Fischer, AR ;
Keith, TP ;
Serino, K ;
Kim, SW ;
DeSanctis, GT ;
Yandava, C ;
Pillari, A ;
Rubin, P ;
Kemp, J ;
Israel, E ;
Busse, W ;
Ledford, D ;
Murray, JJ ;
Segal, A ;
Tinkleman, D ;
Drazen, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (05) :1130-1137
[5]   THE EFFECT OF INHIBITION OF 5-LIPOXYGENASE BY ZILEUTON IN MILD-TO-MODERATE ASTHMA [J].
ISRAEL, E ;
RUBIN, P ;
KEMP, JP ;
GROSSMAN, J ;
PIERSON, W ;
SIEGEL, SC ;
TINKELMAN, D ;
MURRAY, JJ ;
BUSSE, W ;
SEGAL, AT ;
FISH, J ;
KAISER, HB ;
LEDFORD, D ;
WENZEL, S ;
ROSENTHAL, R ;
COHN, J ;
LANNI, C ;
PEARLMAN, H ;
KARAHALIOS, P ;
DRAZEN, JM .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (11) :1059-1066
[6]   Depletion of human monocyte 85-kDa phospholipase A(2) does not alter leukotriene formation [J].
Marshall, LA ;
Bolognese, B ;
Winkler, JD ;
Roshak, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) :759-765
[7]   Antileukotrienes in the treatment of asthma [J].
OByrne, PM ;
Israel, E ;
Drazen, JM .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (06) :472-480
[8]   5-LIPOXYGENASE GENE-EXPRESSION IN HL-60 CELLS DURING DIFFERENTIATION WITH DMSO [J].
PIECHELE, G ;
COLLI, S ;
TREMOLI, E ;
MAGGI, A .
PHARMACOLOGICAL RESEARCH, 1993, 27 (01) :53-60
[9]   Effects of montelukast (MK-0476), a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids [J].
Reiss, TF ;
Sorkness, CA ;
Stricker, W ;
Botto, A ;
Busse, WW ;
Kundu, S ;
Zhang, J .
THORAX, 1997, 52 (01) :45-48
[10]   LEUKOTRIENES - MEDIATORS OF IMMEDIATE HYPERSENSITIVITY REACTIONS AND INFLAMMATION [J].
SAMUELSSON, B .
SCIENCE, 1983, 220 (4597) :568-575